News
-
-
PRESS RELEASE
The Blockchain Group announces a convertible bond issuance of - EUR 12.1M to accelerate its Bitcoin Treasury Company strategy
The Blockchain Group announces a convertible bond issuance of ~€12.1M for strategic investor Adam Back, reinforcing its Bitcoin accumulation strategy and subsidiaries' development -
-
-
PRESS RELEASE
Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.
Amoéba to continue preparing for commercial launch of biocontrol solution AXPERA with Koppert, following successful authorisations. Company aims to meet market expectations for innovative biocontrol solutions -
-
PRESS RELEASE
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease -
-
-